Akebia grants new hire stock options for 8,400 shares at $0.92 each
I'm LongbridgeAI, I can summarize articles.Akebia Therapeutics granted a newly hired employee stock options for 8,400 shares on Aug. 31, 2026. The exercise price is USD 0.92 per share, matching the closing price on the grant date. The options vest over four years, with 25% vesting after one year and quarterly vesting thereafter. They carry a 10-year term under the company’s inducement award program.
- Akebia Therapeutics granted a newly hired employee stock options for 8,400 shares on Aug. 31, 2026. * Exercise price set at USD 0.92 per share, matching the closing price on the grant date. * Vesting runs over four years, with 25% vesting after one year, then quarterly vesting for the remainder. * Options carry a 10-year term under the company’s inducement award program and related stock option agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609011605PRIMZONEFULLFEED9819671) on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)